Celik, B. Et Al. 2020. Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site. PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.2 , 1145-1151.

Celik, B., Bulut, T., & Yalcin, A. D., (2020). Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site. PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.2, 1145-1151.

Celik, BETÜL, Tangul Bulut, And Arzu Didem Yalcin. "Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site," PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.2, 1145-1151, 2020

Celik, BETÜL Et Al. "Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site." PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.2, pp.1145-1151, 2020

Celik, B. Bulut, T. And Yalcin, A. D. (2020) . "Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site." PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.2, pp.1145-1151.

@article{article, author={BETÜL ÇELİK Et Al. }, title={Tissue HE4 Expression Discriminates the Ovarian Serous Carcinoma but Not the Uterine Serous Carcinoma Patients. A New Adjunct to the Origin of the Tumor Site}, journal={PATHOLOGY & ONCOLOGY RESEARCH}, year=2020, pages={1145-1151} }